live attenuated influenza vaccine


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.
Related to live attenuated influenza vaccine: FluMist

live attenuated influenza vaccine

Abbreviation: LAIV
A live virus vaccine made with influenza viruses adapted to replicate in the nose, sinuses, and pharynx but not in the lower respiratory tract. LAIV is typically administered by nasal inhalation rather than by intramuscular injection.
See also: vaccine
References in periodicals archive ?
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Lu is responsible for leading R&D activities for Vivaldi's live attenuated influenza vaccine programs, including further studies to evaluate the vaccine candidates in animal models and establish preclinical safety, in support of Vivaldi's planned IND.
No serious side effects were attributed to either version of the live attenuated influenza vaccine.
There are also new recommendations regarding the use of live attenuated influenza vaccine (LAIV) for healthy children aged 2 through 8 years.
FluMist, sometimes referred to as an LAIV for Live Attenuated Influenza Vaccine, is a new flu vaccine that was licensed in 2003.
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
FluMist, the live attenuated influenza vaccine (LAIV), which is administered as an intranasal spray, is now approved for use among those 2 to 4 years of age.
would deliver about 3 million doses of FluMist, the live attenuated influenza vaccine (MMWR 2005; 54:850).
Aviron and Sang-A plan to develop the live attenuated influenza vaccine for widespread use in children, adults who prefer its intranasal administration over an injection, and for combination use with the inactivated flu shot for improved protection in the elderly.
In June of 2014, live attenuated influenza vaccine (LAIV) was announced by the Advisory Committee on Immunization Practices to be the preferred vaccine in children aged 2-8 years.
The intranasally administered live attenuated influenza vaccine (LAIV), FluMist (MedImmune) is indicated for healthy, nonpregnant persons aged 2 through 49 years.
The same 2 vaccine types are available this year as last: trivalent influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV).